Filing Details
- Accession Number:
- 0001415889-24-028285
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-04 17:20:06
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-04 17:20:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578852 | Elliott Mark Boulding | C/O Ptc Therapeutics, Inc. 500 Warren Corporate Center Drive Warren NJ 07059 | Exec. Vp And Clo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-12-02 | 1,960 | $51.00 | 94,349 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-02 | 1,960 | $52.17 | 92,389 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-12-02 | 83,640 | $51.00 | 176,029 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-02 | 83,640 | $52.26 | 92,389 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-12-03 | 600 | $33.02 | 92,989 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-03 | 600 | $53.04 | 92,389 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-12-03 | 7,720 | $33.02 | 100,109 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-03 | 6,315 | $53.14 | 93,794 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-03 | 1,405 | $54.05 | 92,389 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-12-03 | 1,988 | $33.02 | 94,377 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-12-03 | 1,900 | $53.13 | 92,477 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-12-03 | 88 | $54.14 | 92,389 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-02 | 1,960 | $0.00 | 1,960 | $51.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-02 | 83,640 | $0.00 | 83,640 | $51.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-03 | 600 | $0.00 | 600 | $33.02 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-03 | 7,720 | $0.00 | 7,720 | $33.02 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-12-03 | 1,988 | $0.00 | 1,988 | $33.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 83,640 | 2025-01-02 | No | 4 | M | Direct | |
| 0 | 2025-01-02 | No | 4 | M | Direct | |
| 3,070 | 2029-01-02 | No | 4 | M | Direct | |
| 61,110 | 2029-01-02 | No | 4 | M | Direct | |
| 15,512 | 2029-01-02 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on October 31, 2023.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.00 to $52.83 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $52.00 to $52.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.09 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to 53.995 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.025 to $54.16 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to $53.62 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Currently exercisable.
Billionaire Hedge Funds
